# Najm AI ClinicNote — Family Evidence Packs and Multi-Workflow Activation Wave 4

Status: corrected completion for the beta branch only.

## Baseline and corrected implementation

- Baseline branch: `beta-parent-workflows-and-wave3-v1`
- Starting HEAD: `1c817e3f16470a209ec92a9a5f2741cac8eb2b82`
- Wave 4 branch: `beta-family-evidence-and-wave4-v1`
- Correction: target field provenance and evidence records were rebuilt from exact existing registry sections; four targets with no complete critical evidence remain inactive and fail closed.
- Corrected implementation commit: `b76de4a87d5ddca23b2fae3f3ad4859d8c3197d7` (`fix(wave4): reconcile family evidence provenance`).
- Corrected beta deployment: workflow run [30247206613](https://github.com/hosxam/najm-ai-clinicnote-v2-beta/actions/runs/30247206613), deployed SHA `b76de4a87d5ddca23b2fae3f3ad4859d8c3197d7`, displayed build `b76de4a`.
- Live beta: https://hosxam.github.io/najm-ai-clinicnote-v2-beta/#/beta
- Stable production was not deployed or changed.

## Distinct baseline, families, and targets

- Exact distinct inactive baseline: 1,061 records (1,082 inventory records less 21 incorporated historical components).
- Families processed: 10.
- Distinct workflow targets: 43.
- Active after correction: 457 total workflows.
- Inactive after correction: 1,043 total workflows.
- Wave 4 activations: 39.
- Wave 4 remaining inactive with named critical gaps: 4.

Families: diabetes-care (5), acute-respiratory (5), emergency-assessment (5), perioperative-anaesthetic (4), ent-presentations (4), cardiovascular-review (4), paediatric-acute (4), gastrointestinal (4), renal-monitoring (4), and musculoskeletal-assessment (4).

Remaining Wave 4 gaps:

- `peds-bedwetting-documentation`: no complete paediatric enuresis source.
- `peds-food-allergy-documentation`: no complete paediatric food-allergy documentation source.
- `renal-aki-follow-up-after-discharge`: no AKI-specific post-discharge monitoring source.
- `renal-hemodialysis-clinic-documentation`: no haemodialysis-specific clinic source.

Each remains in the inactive inventory with its exact gap, evaluated organisations, and fail-closed route behavior. No generic or clinically unrelated template substitutes it.

## Source acquisition and reconciliation

- Family searches issued: 10 family strategies, 64 source-document searches.
- Official pages opened: 64.
- Guideline documents located: 64.
- Documents downloaded: 64 (existing registered corpus copies).
- Documents extracted: 64 or exact registered locators available.
- Source registry before/after: 238 / 238.
- Newly accepted sources: 0.
- Accepted existing sources: 64 unique sources.
- Duplicate sources: 0 new duplicates; all 64 were explicitly reconciled to existing registry records.
- Source-access failures: 0 for selected family evidence; unrelated corpus blocked-source states remain governed by the existing registry.
- Extraction failures: 0 for selected family evidence.
- Candidate evaluation: 3,363 / 3,363 terminally evaluated.

## Evidence packs and provenance

- Family evidence packs: 10, with exact source sections and supported field IDs.
- Workflow evidence packs: 43; 39 complete, 4 terminal gap packs.
- Reconciled active Wave 4 fields: 625.
- Every active field has source IDs, exact evidence-statement IDs, population/setting qualifiers, and a matching exact source section.
- Every active internal evidence record has source ID, official URL, exact locator, and locator fingerprint.
- Workflow completeness matrix: 39 activation-ready records and 4 named-gap records.

## Catalogue totals

| Measure | Result |
|---|---:|
| Original workflows | 1,500 |
| Active workflows | 457 |
| Inactive workflows | 1,043 |
| Clinician-facing items | 6,938 |
| Internal evidence records | 75,962 |
| Interactive fields | 4,823 |

Final and interactive manifests agree; the inactive route policy remains fail closed.

## Structured components and outputs

- Wave 4 selectable fields: 78.
- Wave 4 selectable options: 352.
- Wave 4 contradiction rules: 6.
- Archetype outputs added: chronic disease follow-up (10), medication review (2), result review (4), acute symptom assessment (12), emergency presentation (5), anaesthetic assessment (4), paediatric assessment (2).
- SOAP and Quick/Advanced mode mappings remain clinician-review documentation outputs; no treatment or diagnosis is inferred.

## Validation and regression

All required checks passed after provenance correction: family Wave 4 validation, interactive workflows, final manifest, clinician-facing separation, Advanced modes, workflow-item evidence, dependency/archetype/compaction, aliases, section applicability, dependency graph, retirement, data, safety, source evidence, item provenance, hashes, clinical reproducibility, source-recency, source ingestion, independent replay, evidence packs, queue, lint, and build.

Baseline regressions passed:

- 418 baseline active workflows retained within the 457-workflow active set.
- 433 manual defect records.
- 127 baseline selectable controls.
- 111 baseline contradiction groups.
- 21 incorporated redirects.
- Wave 1 `gp-sore-throat`, Wave 2 `derm-eczema`, parent Wave 3, state isolation, Start Fresh, Reset, and archetype output fixtures.

Detailed results: `clinical-expansion-v2/progress/family-wave4/TEST_RESULTS.json`.

## Reproducibility

- Registered/replayed sources: 238 / 238.
- Replay modules: 151.
- Metadata fingerprint: `94f9f350cefa1c964953c2b782df219f0ad5500208a62dd01c9b7e1b5b7c84a5`.
- Replay manifest fingerprint: `ae86b5a4c45b79184061d84776e80d7bb9528559188cc34e02d01673410ba8ba`.
- Replay parity: PASS.
- Persisted provenance and source-recency: PASS.

## Beta deployment and live verification

The corrected branch is deployed only to the beta Pages target. `LIVE_VERIFICATION.json` records the successful workflow run, deployed SHA, displayed build, canonical final-catalogue manifest, no obsolete curated dataset request, route checks, evidence panels, Quick/Advanced routes, inactive fail-closed behavior, alias/filter/search checks, responsive checks, zero console errors, zero failed requests, no local paths, and workflow-scoped temporary draft isolation. Live verification at `2026-07-27T11:52:45+04:00` passed: 1,500 original / 457 active / 1,043 inactive workflows, 6,938 clinician-facing items, 75,962 internal evidence records, and 4,823 interactive fields. Desktop 1440px, tablet 1024px, and mobile 390px had no horizontal overflow; temporary review storage was cleared after testing.

## Protected boundaries

- `public/data` unchanged.
- Canonical signed state unchanged.
- Mappings: 0.
- Clinician approvals: 0.
- Exclusions: 12.
- Stable production untouched.
- No merge, rebase, force-push, signing, approval, or queue continuation.

## Commits

The original logical Wave 4 commits remain preserved. The correction is additive and does not amend, squash, rebase, or rewrite history. The correction commit records exact provenance repair, fail-closed target handling, and validator updates. This documentation update records the corrected deployment and live verification.

## Truthful limitations

The beta remains a clinician-review documentation workspace, not clinical decision support. Four Wave 4 targets remain inactive because the selected existing corpus did not contain complete named critical evidence. Existing international guidance retains its documented jurisdiction and UAE-adaptation limitations. No new source registry records were invented.

NAJM_FAMILY_EVIDENCE_AND_WAVE4_COMPLETE
